SCHEMBL21990934

SCHEMBL21990934

O=C(Nc1ccc(F)c(Cl)c1)c1ccc(F)c(S)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.67
RAB9A P51151 5/20 0.67
KCNQ3 O43525 1/20 0.59
KCNQ2 O43526 1/20 0.59
KCNE1 P15382 1/20 0.59
KCNQ1 P51787 1/20 0.59
MAOB P27338 3/20 0.58
MAPT P10636 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
KDM4E B2RXH2 2/20 0.58
PKM P14618 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAOA P21397 2/20 0.56
SLC2A1 P11166 1/20 0.55
NPSR1 Q6W5P4 2/20 0.53
FADS1 O60427 1/20 0.53
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24771257 0.93 NPC1 (0.65) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL20774335 0.84 NPC1 (0.57) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL21990931 0.83 NPC1 (0.72) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL19479144 0.82 NPC1 (0.67) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL17784044 0.81 NPC1 (0.65) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL19157142 0.81 NPC1 (0.65) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL2679067 0.81 NPC1 (0.73) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL94560 0.81 NPC1 (0.73) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL17784123 0.80 NPC1 (0.47) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL24771971 0.80 NPC1 (0.51) NPC1RAB9AKCNQ3KCNQ2KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227262-B1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS INC (US) 2020-05-13 EP disclosed